Literature DB >> 6205799

Investigation of the idiotypic determinants of IgM monoclonal proteins associated with neuropathy.

S W Evans, N A Gregson, S L Leibowitz, N R Ling.   

Abstract

Occasionally IgM monoclonal proteins (MP) from benign gammopathies bind neural antigens and have been associated with demyelinating peripheral neuropathy. A monoclonal antibody (McAb) has been raised against a cross-reactive idiotypic determinant expressed by three out of 12 MP with specificity for neural antigens. The determinant recognised by this MoAb is only expressed when both H and L chain are properly associated. The idiotypic determinant was not expressed by 130 MP randomly selected from patients without neuropathy nor in polyclonal immunoglobulin preparations obtained from healthy individuals.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6205799      PMCID: PMC1536269     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Neurologic aspects of Waldenstrom's macroglobulinemia; report of a case.

Authors:  J LOGOTHETIS; P SILVERSTEIN; J COE
Journal:  Arch Neurol       Date:  1960-11

2.  IgM-induced specific antibody responses: direct correlation between responsiveness and natural or induced recurrence of the idiotype.

Authors:  F Ivars; D Holmberg; P A Cazenave; A Coutinho
Journal:  Scand J Immunol       Date:  1983-03       Impact factor: 3.487

3.  Specificity and idiotype of M-proteins that react with MAG in patients with neuropathy.

Authors:  T Saito; W H Sherman; N Latov
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

4.  Evidence of unique idiotypic determinants and similar idiotypic determinants on human antithyroglobulin antibodies.

Authors:  T Matsuyama; J Fukumori; H Tanaka
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

5.  Anti-idiotypes to monoclonal anti-H-2 antibodies--I. Contribution of isolated heavy and light chains to idiotype expression.

Authors:  J A Bluestone; J J Metzger; M C Knode; K Ozato; D H Sachs
Journal:  Mol Immunol       Date:  1982-04       Impact factor: 4.407

6.  Structure of antibodies with shared idiotypy: the complete sequence of the heavy chain variable regions of two immunoglobulin M anti-gamma globulins.

Authors:  J D Capra; J M Kehoe
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

7.  Contribution of the H- and L-chains and of the binding site to the idiotypic specificities of mouse anti-GAT antibodies.

Authors:  G Sommé; J R Serra; L Leclercq; J L Moreau; J C Mazie; D Moinier; M Fougerèau; J Thèze
Journal:  Mol Immunol       Date:  1982-08       Impact factor: 4.407

8.  A highly conserved determinant on human rheumatoid factor idiotypes defined by a mouse monoclonal antibody.

Authors:  J L Pasquali; A Urlacher; D Storck
Journal:  Eur J Immunol       Date:  1983-03       Impact factor: 5.532

9.  Monoclonal antibody against a cross-reactive idiotypic determinant found on human autoantibodies with anti-I and -i specificities.

Authors:  S W Evans; T Feizi; R Childs; N R Ling
Journal:  Mol Immunol       Date:  1983-10       Impact factor: 4.407

10.  A common idiotope on human rheumatoid factors identified by a hybridoma antibody.

Authors:  D A Carson; S Fong
Journal:  Mol Immunol       Date:  1983-10       Impact factor: 4.407

View more
  2 in total

1.  Modulation of the murine immune response to human IgG by complexing with monoclonal antibodies. II. Antibody responses to idiotopes of the human IgG paraprotein and of the mouse monoclonal antibodies.

Authors:  N R Ling; D Elliott; J Lowe
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

2.  Expression of a public idiotype by human monoclonal IgM directed to myelin-associated glycoprotein and characterization of the variability subgroup of their heavy and light chains.

Authors:  J C Brouet; K Dellagi; M C Gendron; A Chevalier; C Schmitt; E Mihaesco
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.